Skip to main content
NCBI home page
Protein & Cell logoLink to Protein & Cell
. 2012 Sep 1;3(10):723–725. doi: 10.1007/s13238-012-2810-2

Getting to know the fetal genome non-invasively: now a reality

Maulik M Dhandha 1,✉
PMCID: PMC4875350  PMID: 22941433

The content is available as a PDF (328.8 KB).

References

  1. Anker P., Mulcahy H., Chen X.Q., Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev. 1999;18:65–73. doi: 10.1023/A:1006260319913. [DOI] [PubMed] [Google Scholar]
  2. Chen Z., Fadiel A., Naftolin F., Eichenbaum K.D., Xia Y. Circulation DNA: biological implications for cancer metastasis and immunology. Med Hypotheses. 2005;65:956–961. doi: 10.1016/j.mehy.2005.04.042. [DOI] [PubMed] [Google Scholar]
  3. Evans M.I., Wapner R.J. Invasive prenatal diagnostic procedures. Semin Pernatol. 2005;29:215–218. doi: 10.1053/j.semperi.2005.06.004. [DOI] [PubMed] [Google Scholar]
  4. Fan H.C., Gu W., Wanf J., Blumenfeld Y.J., El-Sayed Y.Y., Quake S.R. Non-invasive prenatal measurement of the fetal genome. Nature. 2012;487:320–324. doi: 10.1038/nature11251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goebel G., Zitt M., Zitt M., Müller H.M. Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias. Dis Markers. 2005;21:105–120. doi: 10.1155/2005/218759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gormally E., Caboux E., Vineis P., Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res. 2007;635:105–117. doi: 10.1016/j.mrrev.2006.11.002. [DOI] [PubMed] [Google Scholar]
  7. Hahn S., Jackson L.G., Kolla V., Mahyuddin A.P., Choolani M. Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies. Expert Rev Mol Diagn. 2009;9:613–621. doi: 10.1586/erm.09.43. [DOI] [PubMed] [Google Scholar]
  8. Hung E.C., Chiu R.W., Lo Y.M. Detection of circulating fetal nucleic acids: a review of methods and applications. J Clin Pathol. 2009;62:308–313. doi: 10.1136/jcp.2007.048470. [DOI] [PubMed] [Google Scholar]
  9. Lo Y.M., Tein M.S., Lau T.K., Haines C.J., Leung T.N., Poon P.M., Wainscoat J.S., Johnson P.J., Chang A.M., Hjelm N.M. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62:768–775. doi: 10.1086/301800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lo Y.M., Chan K.C., Sun H., Chen E.Z., Jiang P., Lun F.M., Zheng Y.W., Leung T.Y., Lau T.K., Cantor C.R., et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010;2:1ra91. doi: 10.1126/scitranslmed.3001720. [DOI] [PubMed] [Google Scholar]
  11. Lo Y.M., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W.G., Wainscoat J.S. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–487. doi: 10.1016/S0140-6736(97)02174-0. [DOI] [PubMed] [Google Scholar]
  12. Lo Y.M., Zhang J., Leung T.N., Lau T.K., Chang A.M., Hjelm N.M. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999;64:218–224. doi: 10.1086/302205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lo, Y.M. (2012). Non-invasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA. Open Biol 2. (In Press) [DOI] [PMC free article] [PubMed]
  14. Lun F.M.F., Chiu R.W.K., Chan K.C.A., Leung T.Y., Lau T.K., Lo Y.M.D. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem. 2008;54:1664–1672. doi: 10.1373/clinchem.2008.111385. [DOI] [PubMed] [Google Scholar]
  15. Malone F.D., Canick J.A., Ball R.H., Nyberg D.A., Comstock C.H., Bukowski R., Berkowitz R.L., Gross S.J., Dugoff L., Craigo S.D., et al. First-trimester or second trimester screening, or both, for Down’s syndrome. N Engl J Med. 2005;353:2001–2011. doi: 10.1056/NEJMoa043693. [DOI] [PubMed] [Google Scholar]
  16. Mandel P., Metais P. Les acides nucleiques du plasm sanguine chez I’homme. C.R. Acad Sci Paris. 1948;142:241–243. [PubMed] [Google Scholar]
  17. Palomaki G.E., Deciu C., Kloza E.M., Lambert-Messerlian G.M., Haddow J.E., Neveux L.M., Ehrich M., van den Boom D., Bombard A.T., Grody W.W., et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Gene Med. 2012;14:296–305. doi: 10.1038/gim.2011.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rhodes A., Wort S.J., Thomas H., Collinson P., Bennett E.D. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care. 2006;10:R60. doi: 10.1186/cc4894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Stroun M., Lyautey J., Lederrey C., Olson-Sand A., Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta. 2001;313:139–142. doi: 10.1016/S0009-8981(01)00665-9. [DOI] [PubMed] [Google Scholar]
  20. Sykes P.J., Neoh S.H., Brisco M.J., Hughes E., Condon J., Morley A.A. Quantitation of targets for PCR by use of limiting dilution. Biotechniques. 1992;13:444–449. [PubMed] [Google Scholar]
  21. Vogelstein B., Kinzler K.W. Digital PCR. Proc Natl Acad Sci U S A. 1999;96:9236–9241. doi: 10.1073/pnas.96.16.9236. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES